TY - JOUR
T1 - Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis
AU - Müller, Jannis
AU - Sharmin, Sifat
AU - Lorscheider, Johannes
AU - Ozakbas, Serkan
AU - Karabudak, Rana
AU - Horakova, Dana
AU - Weinstock-Guttman, Bianca
AU - Shaygannejad, Vahid
AU - Etemadifar, Masoud
AU - Alroughani, Raed
AU - Patti, Francesco
AU - Eichau, Sara
AU - Prat, Alexandre
AU - Lugaresi, Alessandra
AU - Tomassini, Valentina
AU - Kermode, Allan G.
AU - Amato, Maria Pia
AU - Turkoglu, Recai
AU - Altintas, Ayse
AU - Buzzard, Katherine
AU - Soysal, Aysun
AU - Van Der Walt, Anneke
AU - Butzkueven, Helmut
AU - Blanco, Yolanda
AU - Gerlach, Oliver
AU - Khoury, Samia J.
AU - Barnett, Michael
AU - John, Nevin
AU - Lechner-Scott, Jeannette
AU - Foschi, Matteo
AU - Surcinelli, Andrea
AU - Van Pesch, Vincent
AU - Prevost, Julie
AU - Sa, Maria Jose
AU - Maimone, Davide
AU - D'hooghe, Marie
AU - Hughes, Stella
AU - Hodgkinson, Suzanne
AU - Mcguigan, Chris
AU - Cartechini, Elisabetta
AU - Taylor, Bruce
AU - Spitaleri, Daniele
AU - Slee, Mark
AU - Mccombe, Pamela
AU - Yamout, Bassem
AU - Benkert, Pascal
AU - Kuhle, Jens
AU - Kappos, Ludwig
AU - Roos, Izanne
AU - Kalincik, Tomas
AU - MSBase Study Group
AU - Havrdova, Eva Kubala
AU - Girard, Marc
AU - Duquette, Pierre
AU - Fabis-Pedrini, Marzena
AU - Carroll, William M.
AU - Skibina, Olga
AU - Gouider, Riadh
AU - Mrabet, Saloua
AU - Ramo-Tello, Cristina
AU - Solaro, Claudio
AU - Habek, Mario
AU - Van Wijmeersch, Bart
AU - Ampapa, Radek
AU - Macdonell, Richard
AU - Oreja-Guevara, Celia
AU - De Gans, Koen
AU - Laureys, Guy
AU - Oh, Jiwon
AU - Garber, Justin
AU - Gray, Orla
AU - Agüera-Morales, Eduardo
AU - Sanchez-Menoyo, Jose Luis
AU - Castillo-Triviño, Tamara
AU - Grigoriadis, Nikolaos
AU - Petersen, Thor
AU - Hardy, Todd A.
AU - Vucic, Steve
AU - Reddel, Stephen
AU - Ramanathan, Sudarshini
AU - Al-Asmi, Abdullah
AU - Simu, Mihaela
AU - Baghbanian, Seyed Mohammad
AU - Poehlau, Dieter
AU - Al-Harbi, Talal
AU - Rojas, Juan Ignacio
AU - Deri, Norma
AU - Lalive, Patrice
AU - Cambron, Melissa
AU - Csepany, Tunde
AU - Shuey, Neil
AU - Willekens, Barbara
AU - Shaw, Cameron
AU - Decoo, Danny
AU - Massey, Jennifer
AU - Yaldizli, Özgür
AU - Derfuss, Tobias
AU - Granziera, Cristina
PY - 2025/6
Y1 - 2025/6
N2 - Importance: Progression independent of relapse activity (PIRA) is a significant contributor to long-term disability accumulation in relapsing-remitting multiple sclerosis (MS). Prior studies have used varying PIRA definitions, hampering the comparability of study results. Objective: To compare various definitions of PIRA. Design, Setting, and Participants: This cohort study involved a retrospective analysis of prospectively collected data from the MSBase registry from July 2004 to July 2023. The participants were patients with MS from 186 centers across 43 countries who had clinically definite relapsing-remitting MS, a complete minimal dataset, and 3 or more documented Expanded Disability Status Scale (EDSS) assessments. Exposure: Three-hundred sixty definitions of PIRA as combinations of the following criteria: baseline disability (fixed baseline with re-baselining after PIRA, or plus re-baselining after relapses, or plus re-baselining after improvements), minimum confirmation period (6, 12, or 24 months), confirmation magnitude (EDSS score at/above worsening score or at/above threshold compared with baseline), freedom from relapse at EDSS score worsening (90 days prior, 90 days prior and 30 days after, 180 days prior and after, since previous EDSS assessment, or since baseline), and freedom from relapse at confirmation (30 days prior, 90 days prior, 30 days before and after, or between worsening and confirmation). Main Outcome and Measure: For each definition, we quantified PIRA incidence and persistence (ie, absence of a 3-month confirmed EDSS improvement over ≥5 years). Results: Among 87239 patients with MS, 33303 patients fulfilled the inclusion criteria; 24152 (72.5%) were female and 9151 (27.5%) were male. At the first visits, the mean (SD) age was 36.4 (10.9) years; 28052 patients (84.2%) had relapsing-remitting MS, and the median (IQR) EDSS score was 2.0 (1.0-3.0). Participants had a mean (SD) 15.1 (11.9) visits over 8.9 (5.2) years. PIRA incidence ranged from 0.141 to 0.658 events per decade and persistence from 0.753 to 0.919, depending on the definition. In particular, the baseline and confirmation period influenced PIRA detection. The following definition yielded balanced incidence and persistence: a significant disability worsening compared with a baseline (reset after each PIRA event, relapse, and EDSS score improvement), in absence of relapses since the last EDSS assessment, confirmed with EDSS scores (not preceded by relapses within 30 days) that remained above the worsening threshold for at least 12 months. Conclusion and Relevance: Incidence and persistence of PIRA are determined by the definition used. The proposed standardized definition aims to enhance comparability among studies.
AB - Importance: Progression independent of relapse activity (PIRA) is a significant contributor to long-term disability accumulation in relapsing-remitting multiple sclerosis (MS). Prior studies have used varying PIRA definitions, hampering the comparability of study results. Objective: To compare various definitions of PIRA. Design, Setting, and Participants: This cohort study involved a retrospective analysis of prospectively collected data from the MSBase registry from July 2004 to July 2023. The participants were patients with MS from 186 centers across 43 countries who had clinically definite relapsing-remitting MS, a complete minimal dataset, and 3 or more documented Expanded Disability Status Scale (EDSS) assessments. Exposure: Three-hundred sixty definitions of PIRA as combinations of the following criteria: baseline disability (fixed baseline with re-baselining after PIRA, or plus re-baselining after relapses, or plus re-baselining after improvements), minimum confirmation period (6, 12, or 24 months), confirmation magnitude (EDSS score at/above worsening score or at/above threshold compared with baseline), freedom from relapse at EDSS score worsening (90 days prior, 90 days prior and 30 days after, 180 days prior and after, since previous EDSS assessment, or since baseline), and freedom from relapse at confirmation (30 days prior, 90 days prior, 30 days before and after, or between worsening and confirmation). Main Outcome and Measure: For each definition, we quantified PIRA incidence and persistence (ie, absence of a 3-month confirmed EDSS improvement over ≥5 years). Results: Among 87239 patients with MS, 33303 patients fulfilled the inclusion criteria; 24152 (72.5%) were female and 9151 (27.5%) were male. At the first visits, the mean (SD) age was 36.4 (10.9) years; 28052 patients (84.2%) had relapsing-remitting MS, and the median (IQR) EDSS score was 2.0 (1.0-3.0). Participants had a mean (SD) 15.1 (11.9) visits over 8.9 (5.2) years. PIRA incidence ranged from 0.141 to 0.658 events per decade and persistence from 0.753 to 0.919, depending on the definition. In particular, the baseline and confirmation period influenced PIRA detection. The following definition yielded balanced incidence and persistence: a significant disability worsening compared with a baseline (reset after each PIRA event, relapse, and EDSS score improvement), in absence of relapses since the last EDSS assessment, confirmed with EDSS scores (not preceded by relapses within 30 days) that remained above the worsening threshold for at least 12 months. Conclusion and Relevance: Incidence and persistence of PIRA are determined by the definition used. The proposed standardized definition aims to enhance comparability among studies.
KW - multiple sclerosis
KW - relapse activity
KW - relapsing-remitting multiple sclerosis
UR - https://www.scopus.com/pages/publications/105002792941
U2 - 10.1001/jamaneurol.2025.0495
DO - 10.1001/jamaneurol.2025.0495
M3 - Article
AN - SCOPUS:105002792941
SN - 2168-6149
VL - 82
SP - 614
EP - 625
JO - JAMA Neurology
JF - JAMA Neurology
IS - 6
ER -